Related Experiment Video
Updated: Jun 2, 2026
06:07
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Nitroimidazoles as anti-tumor agents
1State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, People's Republic of China.
Anti-Cancer Agents in Medicinal Chemistry
|April 28, 2011
Summary
Nitroimidazoles are versatile compounds explored for cancer treatment, acting as radiosensitizers and bio-reductive prodrugs. This review details their development and mechanisms for enhanced anti-tumor efficacy.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- Cancer treatment remains a significant challenge, despite advancements in anti-tumor agents.
- Nitroimidazoles, known radiosensitizers since the 1950s, possess diverse bioactivities relevant to cancer therapy.
Purpose of the Study:
- To review the development of nitroimidazoles as anti-cancer agents.
- To explore their mechanisms of action as radiosensitizers, bio-reductive prodrugs, and other anti-tumor modalities.
- To discuss the future prospects and trends in nitroimidazole-based cancer therapy.
Main Methods:
- Literature review of nitroimidazoles in cancer treatment.
- Analysis of their development as radiosensitizers and prodrugs.
- Examination of their anti-tumor mechanisms and therapeutic applications.
Main Results:
- Nitroimidazoles have evolved from radiosensitizers to include roles as bio-reductive prodrugs.
- Their anti-tumor effects are mediated through various mechanisms, including DNA damage and hypoxia targeting.
- Significant progress has been made in developing nitroimidazoles for diverse cancer types.
Conclusions:
- Nitroimidazoles represent a promising class of compounds for cancer therapy.
- Further research into their development and application holds significant potential for improving anti-tumor strategies.
- The future trend points towards novel nitroimidazole derivatives with enhanced efficacy and targeted delivery.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...